On January 10, the first day of the pandemic, the U.S. government sent a message to the public to avoid wearing masks at all public places.
The public, of course, has a right to know who’s wearing masks and how they’re doing it.
But it’s a fairly broad message.
The CDC did not respond to our request for comment about why it didn’t just say, “We don’t know.”
In the wake of the outbreak, several health officials have suggested that the public should get a flu vaccine.
A CDC official told the New York Times that the agency has “no plans to expand the availability of the flu vaccine,” despite the pandemics’ increased demand.
The CDC and other federal agencies have been working to develop a vaccine. “
But the best way to make sure that people who are in the United States are protected is to get a vaccine.”
The CDC and other federal agencies have been working to develop a vaccine.
In January, the CDC began conducting tests on new strains of influenza virus.
In January, a vaccine called the AZT-V1 vaccine was released.
It is designed to prevent the development of a vaccine-resistant strain of influenza and is expected to be available by early 2018.
The vaccine’s manufacturer, AstraZeneca, also announced that it would make another version of the vaccine, called AZT2, that would be made available by the end of 2019.
The company did not comment on the availability timeline.
In the meantime, the government has been pushing to expand its stockpile of influenza vaccines.
In August, the Centers for Disease Control and Prevention released the first batch of vaccine.
The FDA has been working on its own version of a flu vaccines, called the influenza vaccine.
The agency released its first version of this vaccine in September.
And, finally, in October, the federal government released a plan to expand coverage for the influenza vaccines it has already produced.
This article has been updated with additional information.
Follow David Sirota on Twitter at @davidsirota and @Wired_UK.